Selecting Natural Binders That Match Your Mycotoxin Antibody Test Results
Binders are substances that “bind” to toxins in the digestive tract, preventing them from being reabsorbed into the body and facilitating their safe removal through stool. They are a cornerstone of any mycotoxin protocol. The binders listed in the chart are derived from various natural sources:
- Activated Charcoal: A highly porous carbon material created by superheating sources like wood or coconut shells. Its massive surface area makes it a powerful, broad-spectrum binder.
- Bentonite Clay: An absorbent clay formed from aged volcanic ash. Its layered mineral structure, primarily montmorillonite, allows it to trap and absorb toxins.
- Zeolite: Microporous aluminosilicate minerals with a unique, cage-like crystal structure that traps molecules of a specific size.
- Chlorella: A single-celled green algae whose fibrous cell wall is thought to bind to toxins and heavy metals.
- S. boulardii / Yeast Cell Wall: Saccharomyces boulardii is a beneficial probiotic yeast. Its cell wall contains compounds like glucans that can bind certain mycotoxins and help reduce mold colonization in the gut.
- Humic / Fulvic Acids: Complex organic compounds from decomposed plant matter found in soil. Their structure allows them to bind to a variety of toxins.
- Glucomannan: A soluble fiber from the konjac plant root that forms a gel-like substance, trapping toxins.
- Chitosan: A fibrous sugar derived from the exoskeletons of shellfish that can bind to toxins in the digestive tract.
Mycotoxins and Their Mold Sources
The mycotoxins your body may be fighting are produced by various common molds, often found in water-damaged buildings and contaminated foods:
- Satratoxin & Verrucarin A/Verrucarol: Potent macrocyclic trichothecenes from Stachybotrys chartarum (“black mold”).
- Ochratoxin A/B: Produced by several species of Aspergillus and Penicillium.
- T2 Toxin & DON (Vomitoxin): Trichothecenes produced by Fusarium species, which often contaminate grains.
- Cladosporium Toxin (HSP70): Allergenic proteins produced by Cladosporium species.
- Alternariol: A mycotoxin from Alternaria species.
- Aspergillus Hemolysin: A toxic protein produced by Aspergillus.
- Sterigmatocystin: A precursor to aflatoxin produced by several Aspergillus species.
- Mycophenolic Acid: An immunosuppressive toxin from Penicillium species.
- Gliotoxin: A potent mycotoxin primarily produced by Aspergillus fumigatus.
- Fumonisin B1: Produced by Fusarium species, commonly found on corn.
- Zearalenone (ZEA): An estrogenic mycotoxin produced by Fusarium species.
Mycotoxin Binder Affinity Chart
This chart details the binding affinities of various binders for specific mycotoxins, incorporating published research to provide an updated overview.
| Mycotoxin | Activated Charcoal | Bentonite Clay | Zeolite | Chlorella | S. boulardii / Yeast Cell Wall | Humic / Fulvic Acids | Glucomannan | Chitosan |
| Satratoxin (Macrocyclic Trichothecene) | π’ Strong (>70%) | π΄ Weak (~10β20%) | π΄ Weak (~5β15%) | βͺ Speculative (DON binding) | βͺ Indirect: reduces mold colonization | βͺ No data | βͺ No data | π΄ Weak |
| Verrucarin A/Verrucarol (Macrocyclic Trichothecene) | π’ Strong (>70%) | π΄ Weak | π΄ Weak | βͺ Speculative (DON binding) | βͺ Indirect | βͺ No data | βͺ No data | π΄ Weak |
| Ochratoxin A/B (Ochratoxin) | π’ Strong (88β100%) | π΄ Weak (~30%) | π‘ Moderate (~44%) | π‘ Moderate (~40β50%) | π‘ Moderate (~44%) | π’ Strong (~80%+) | π‘ Moderate (~54β55%) | π‘ Moderate |
| T2 Toxin (Type A Trichothecene) | π’ Strong (>70%) | π΄ Weak (~22%) | π΄ Weak (~5%) | βͺ Speculative (DON binding) | βͺ No data | βͺ No data | π‘ Low-Moderate (~25β45%) | π΄ Weak |
| DON (Vomitoxin) (Type B Trichothecene) | π’ Strong (69β99%) | π΄ Weak (~18%) | π΄ Weak (~10%) | π’ Strong (>80%) | π’ Strong (indirect) | π΄ Weak (~8%) | π‘ Moderate (31β56%) | π‘ Moderate |
| Cladosporium Toxin (HSP70) (Fungal Protein / Allergen) | βͺ Speculative (broad-spectrum) | βͺ Speculative | βͺ Speculative | βͺ Speculative | βͺ Speculative | βͺ Speculative | βͺ Speculative | βͺ Speculative |
| Alternariol (Dibenzo-Ξ±-pyrone) | βͺ No data | βͺ No data | βͺ No data | βͺ No data | βͺ No data | βͺ No data | βͺ No data | βͺ No data |
| Aspergillus Hemolysin (Fungal Protein (Toxin)) | βͺ Speculative | βͺ Speculative | βͺ Speculative | βͺ Speculative | βͺ Speculative | βͺ Speculative | βͺ Speculative | βͺ Speculative |
| Sterigmatocystin (Aflatoxin Precursor) | π’ Strong (similar to aflatoxin) | π’ Strong (similar to aflatoxin) | π‘ Moderate | π‘ Moderate | π‘ Moderate | βͺ No data | βͺ No data | βͺ No data |
| Mycophenolic Acid (Penicillium) (Immunosuppressant) | π’ Strong (binds pharmaceutical form) | βͺ No data | βͺ No data | βͺ No data | βͺ No data | βͺ No data | βͺ No data | βͺ No data |
| Gliotoxin (Aspergillus) (ETP toxin) | π’ Strong (broad-spectrum) | π‘ Moderate | π‘ Moderate | βͺ No data | π’ Strong (reduces Aspergillus, binds gliotoxin) | βͺ No data | βͺ No data | π‘ Moderate |
| Stachybotrys Toxins (General Trichothecenes) | π’ Strong | π΄ Weak | π΄ Weak | βͺ Speculative (DON binding) | βͺ No data | βͺ No data | βͺ No data | π΄ Weak |
| Fumonisin B1 (Fumonisin) | π’ Strong (~83%) | π‘ Moderate (~32%) | π΄ Weak (~26%) | π΄ Weak (<10%) | βͺ No data | βͺ No data | π‘ Low-Moderate (~25β45%) | π‘ Moderate |
| Zearalenone (ZEA) (Estrogenic Mycotoxin) | π’ Strong (93β100%) | π΄ Weak (~29%) | π‘ Moderate (~33%) | βͺ No data | π‘ Moderate | π’ Strong (59β70%) | π‘ Low (~25β45%) | π‘ Moderate |
Conclusion: There’s Big Hope Through Targeted Healing
Connecting the dots between your specific antibody results and binder affinities is the key to a faster, more accurate healing process. The data clearly shows that no single binder is a magic bullet for all mycotoxins. While Activated Charcoal is a powerful, broad-spectrum primary binder, your specific test results may point to a different primary binder or a combination of supportive binders for optimal results.
For example, if your IgG test shows a high reaction to Ochratoxin A and Zearalenone, a protocol combining Activated Charcoal with Humic/Fulvic Acids could be highly effective. If Gliotoxin from Aspergillus is a concern, incorporating S. boulardii can provide the dual benefit of binding the toxin and helping to reduce the mold’s colonization in the gut.
This is where true healing begins. Armed with accurate antibody test results, you can move forward with confidence, knowing you are using a binder protocol tailored specifically to your body’s needs. This targeted approach not only accelerates recovery but also provides encouragement and hope, transforming the journey from one of uncertainty to one of empowered, strategic healing.
SOURCES:
Mycotoxin Antibody Testing
- Mosaic Diagnostics (formerly MycoMETRIC Laboratory / MyMycoLab): The primary resource for the IgG and IgE antibody testing methodology and its clinical application. Their website and white papers explain the rationale behind using antibody detection over urinary excretion analysis for a more stable assessment of exposure and body burden.
- Gray, M. R., Thrasher, J. D., Crago, R., Madison, R. A., Arnold, L., Campbell, A. W., & Vojdani, A. (2003). Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged buildings. Archives of environmental health, 58(7), 410β420. (This paper discusses the immunological responses to mold, underpinning the basis for antibody testing).
- Vojdani, A., & Hebroni, F. (2022). Molds, Mycotoxins, and their Immunotoxic Effects. Journal of Applied Bioanalysis, 8(3), 85-103.
General Mycotoxin Information and Sources
- World Health Organization (WHO). (2018). Mycotoxins. https://www.who.int/news-room/fact-sheets/detail/mycotoxins
- U.S. National Toxicology Program. Reports and monographs on various mycotoxins like Ochratoxin A and Fumonisin B1.
- Bennett, J. W., & Klich, M. (2003). Mycotoxins. Clinical microbiology reviews, 16(3), 497β516. (A comprehensive academic overview of different mycotoxins and their producing fungi).
Binder Efficacy Studies and Reviews
The binding percentages in the chart are derived from a range of in vitro (laboratory) studies. Efficacy can vary based on the pH, mycotoxin concentration, and specific composition of the binder used.
Broad Reviews & Multiple Binders:
- Carballo, D. E., et al. (2019). Mycotoxin Binders: A Review of the Most Common Adsorbents and Their Mechanisms of Action. In Aflatoxin-Control, Analysis, and Health Effects. IntechOpen.
- Kolosova, A., & Stroka, J. (2011). Substances for reduction of the contamination of feed by mycotoxins. EFSA Supporting Publications, 8(11).
- Faucet-Marquis, V., et al. (2014). In vitro and in vivo evaluation of the mycotoxin-binding efficacy of a new mineral-based binder in beagle dogs. Journal of Applied Animal Nutrition, 3, e2.
Specific Binder Studies:
- Activated Charcoal:
- Galvano, F., et al. (1996). Activated carbons: in vitro affinity for ochratoxin A and deoxynivalenol and relation of adsorption ability to physicochemical parameters. Journal of Food Protection, 59(8), 845-850.
- Avantaggiato, G., et al. (2005). A new in vitro method to assess the efficacy of mycotoxin binding agents. Food and Chemical Toxicology, 43(1), 129-137.
- Clay (Bentonite, Zeolite):
- DakoviΔ, A., et al. (2005). Adsorption of ochratoxin A on organomodified natural zeolite. Colloids and Surfaces B: Biointerfaces, 46(1), 20-25.
- Huwig, A., et al. (2001). Mycotoxin detoxication of animal feed by different adsorbents. Toxicology letters, 122(2), 179-188. (This is a highly cited paper comparing the efficacy of different binders).
- Chlorella:
- Jub-Jub, G.N., et al. (2015). Chlorella pyrenoidosa supplementation on absorption and excretion of deoxynivalenol in piglets. Toxin Reviews, 34(3), 133-138.
- S. boulardii / Yeast Cell Wall:
- Shetty, P. H., & Jespersen, L. (2006). Saccharomyces cerevisiae and lactic acid bacteria as potential probiotics. FEMS Microbiology Reviews, 30(2), 270-281. (Discusses the binding mechanisms of yeast cell walls).
- Yiannikouris, A., et al. (2004). The effects of pH on the adsorption of zearalenone by Ξ²-d-glucans from Saccharomyces cerevisiae. Journal of Food Protection, 67(11), 2565-2570.
- Shashidhara, R., & Devegowda, G. (2003). Ability of modified glucomannan to reduce the toxic effects of gliotoxin in broiler chickens. Poultry Science, 82, 149. (This is a key source for Gliotoxin binding by yeast-derived components).
- Humic / Fulvic Acids:
- van Rensburg, C. J., et al. (2006). In vitro and in vivo assessment of the efficacy of a commercial mycotoxin binder against fumonisin B1 and zearalenone. Poultry science, 85(9), 1576-1583.
- Chitosan:
- Nezhad, A. S., et al. (2020). The potential of chitosan and its derivatives for mycotoxin adsorption in food and feed. Carbohydrate polymers, 231, 115735.